These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 14645135

  • 1. Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.
    Whelan SA, Hart GW.
    Circ Res; 2003 Nov 28; 93(11):1047-58. PubMed ID: 14645135
    [Abstract] [Full Text] [Related]

  • 2. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE, Cheung WD, Hart GW.
    Methods Mol Biol; 2004 Nov 28; 284():175-94. PubMed ID: 15173616
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Global identification of O-GlcNAc-modified proteins.
    Nandi A, Sprung R, Barma DK, Zhao Y, Kim SC, Falck JR, Zhao Y.
    Anal Chem; 2006 Jan 15; 78(2):452-8. PubMed ID: 16408927
    [Abstract] [Full Text] [Related]

  • 5. Dynamic nuclear and cytoplasmic glycosylation: enzymes of O-GlcNAc cycling.
    Iyer SP, Hart GW.
    Biochemistry; 2003 Mar 11; 42(9):2493-9. PubMed ID: 12614143
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Does O-GlcNAc play a role in neurodegenerative diseases?
    Lefebvre T, Guinez C, Dehennaut V, Beseme-Dekeyser O, Morelle W, Michalski JC.
    Expert Rev Proteomics; 2005 Apr 11; 2(2):265-75. PubMed ID: 15892570
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.
    Hart GW, Housley MP, Slawson C.
    Nature; 2007 Apr 26; 446(7139):1017-22. PubMed ID: 17460662
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. O-GlcNAc modification: a nutritional sensor that modulates proteasome function.
    Zachara NE, Hart GW.
    Trends Cell Biol; 2004 May 26; 14(5):218-21. PubMed ID: 15130576
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T, Masson E, Pagesy P.
    Diabetes Metab; 2010 Dec 26; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tools for probing and perturbing O-GlcNAc in cells and in vivo.
    Cecioni S, Vocadlo DJ.
    Curr Opin Chem Biol; 2013 Oct 26; 17(5):719-28. PubMed ID: 23906602
    [Abstract] [Full Text] [Related]

  • 17. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY, Thomasson MS, Lin AJ, Sweeney MM, Macnaughtan MA.
    J Biotechnol; 2013 Dec 26; 168(4):315-23. PubMed ID: 24140293
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.